Artia Global Partners LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Artia Global Partners LP disclosed 33 US equity positions worth $248.0m in its Q4 2024 13F filing. The largest position was SLNOEUR at 9.0% of the reported book, followed by MERUS N V and ITCIEUR. Against the Q3 2024 filing, it opened 8 new positions, added to 11 and reduced 3 among the top 33 holdings.
What did Artia Global Partners LP own in Q4 2024? Top 33 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | SLNOEUR SOLENO THERAPEUTICS INC | 9.0% | $22.2m | 494,424 | 80% | added | |
| 2 | MERUS N V | 7.9% | $19.5m | 463,840 | 479% | added | |
| 3 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 7.4% | $18.4m | 219,719 | 1% | added | |
| 4 | ACLXGBX ARCELLX INC | 7.1% | $17.6m | 229,785 | – | new | |
| 5 | NVO NOVO-NORDISK A S | Healthcare | 6.9% | $17.2m | 200,000 | -73% | reduced |
| 6 | NUVALENT INC | 6.4% | $16.0m | 204,045 | 1222% | added | |
| 7 | PCVX VAXCYTE INC | Healthcare | 5.4% | $13.3m | 162,255 | 113% | added |
| 8 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 5.4% | $13.3m | 56,400 | 61% | added |
| 9 | AZN ASTRAZENECA PLC | Healthcare | 5.0% | $12.5m | 190,752 | 0% | held |
| 10 | RVMD REVOLUTION MEDICINES INC | Healthcare | 5.0% | $12.4m | 284,190 | 196% | added |
| 11 | VRNA VERONA PHARMA PLC | 4.8% | $11.9m | 255,318 | 72% | added | |
| 12 | INSM INSMED INC | Healthcare | 4.7% | $11.6m | 167,939 | 217% | added |
| 13 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 4.6% | $11.3m | 293,851 | 136% | added |
| 14 | JANX JANUX THERAPEUTICS INC | Healthcare | 3.5% | $8.7m | 162,976 | – | new |
| 15 | ARGX ARGENX SE | Healthcare | 2.8% | $7.0m | 11,311 | -25% | reduced |
| 16 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.5% | $6.1m | 45,000 | 0% | held |
| 17 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.5% | $3.6m | 90,279 | -83% | reduced |
| 18 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 1.1% | $2.8m | 50,000 | – | new |
| 19 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 0.9% | $2.3m | 45,765 | 0% | held | |
| 20 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.9% | $2.3m | 102,900 | – | new |
| 21 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 0.8% | $1.9m | 53,930 | 0% | held | |
| 22 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.8% | $1.9m | 100,000 | – | new |
| 23 | TGTX TG THERAPEUTICS INC | Healthcare | 0.7% | $1.6m | 54,515 | – | new |
| 24 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.7% | $1.6m | 216,700 | 39% | added |
| 25 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.6% | $1.6m | 40,000 | 0% | held |
| 26 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.6% | $1.5m | 421,359 | 0% | held |
| 27 | NEWAMSTERDAM PHARMA COMPANY | 0.6% | $1.4m | 54,285 | 0% | held | |
| 28 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.5% | $1.3m | 80,380 | 0% | held | |
| 29 | CRL CHARLES RIV LABS INTL INC | Healthcare | 0.5% | $1.2m | 6,305 | 0% | held |
| 30 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 0.5% | $1.2m | 20,811 | – | new |
| 31 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.4% | $1.0m | 7,440 | 0% | held |
| 32 | ANNX ANNEXON INC | Healthcare | 0.4% | $883.5k | 172,226 | 0% | held |
| 33 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.3% | $768.7k | 16,650 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.